1. |
黄志明, 韩银发, 李铮. 睾酮补充治疗是否增加患者良性前列腺增生风险的研究[J]. 中国男科学杂志, 2002; 16(5): 364~366, 369.
|
2. |
Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men[J]. Am J Epidemio, 1998; 147(8): 750-754.
|
3. |
Gray A, Feldman HA, Mckinlay JB, Longcope C. Age, disease and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study[J]. J Clin Endocrinol Metab, 1991; 73(5): 1016-1025.
|
4. |
Barrett-connor E, Von Mühlen DG, Kritz-silverstein D. Bioavaolable testosterone and depressed mood in older men: The Rancho Bernardo Study[J]. J Clin Endocrinol Metab, 1999; 84(2): 573-577.
|
5. |
Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. The Testosterone Gel Study Group, Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group[J]. J Clin Endocrinol Metab, 2000; 85(8): 2839-2853.
|
6. |
Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age[J]. J Clin Endocrinol Metab, 1999; 84(8): 2647-2653.
|
7. |
Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status[J]. ournals of Gerontology Series A-Biological Sciences & Medical Sciences, 2003; 58(7): 618-625.
|
8. |
Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, Casaburi R, Bhasin S. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension[J]. J Clin Endocrinol Metabo, 2003; 88(4): 1478-1485.
|
9. |
Pope HG Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial[J]. Am J Psychiatry, 2003; 160(1): 105-111.
|
10. |
Cavallini G, Caracciolo S, Vitali G, Modenini F, Biagiotti G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging[J]. Urology, 2004; 63(4): 641-646.
|
11. |
Leibenluft E, Schmidt PJ, Turner EH, Danaceau MA, Ashman SB, Wehr TA, Rubinow DR. Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men[J]. J Clin Endocrinol Metab, 1997; 82(10): 3203-3207.
|
12. |
Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency[J]. J Clin Endocrinol Metab, 2001; 86(9): 4078-4088.
|
13. |
Bergamini E. Tstosterone and sugar transport in levator ani muscle of rat[J]. Biochim Biophys Acta, 1969; 193(1): 193-202.
|
14. |
Park NC, Yan BQ, Chung JM, Lee KM. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency[J]. Aging Male, 2003; 6(2): 86-93.
|
15. |
Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men[J]. J Clin Endocrinol Metab, 2003; 88(8): 3605-3613.
|
16. |
Huang ZM, Han YF, Li Z. The study of whether testosterone supplement therapy improving the risk of benign prostatic hyperplasia[J]. Chinese Male Science Journal, 2002; 16(5): 364-366, 369.
|
17. |
Behre HM, Bohmeyer J, Nieschlag E. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls[J]. Clin Endocrinol (Oxf), 1994; 40(3): 341-349.
|
18. |
Gooren LJ. A ten-year safety study of the oral androgen testosterone undecanoate[J]. J Androl, 1994; 15(3): 212-215.
|